CSIMarket



Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Operating Income Growth by Quarter and Year

Pfizer Inc's Operating Income results by quarter and year




PFE Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 3,001.00 341.00 1,535.00
III Quarter October - 6,142.00 3,324.00 11,045.00
II Quarter July - 5,611.00 3,091.00 4,266.00
I Quarter April 9,401.00 4,679.00 4,105.00 4,414.00
FY   9,401.00 19,433.00 10,861.00 21,260.00



PFE Operating Income first quarter 2022 Y/Y Growth Comment
Pfizer Inc achieved in the first quarter 2022, above Company average Operating Income surge of 100.92% year on year, to $ 9,401.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Operating Income growth. While Pfizer Inc' s Operating Income doubling of 100.92% ranks overall at the positon no. 237 in the first quarter 2022.

Explain Operating Income growth


PFE Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - 780.06 % -77.79 % -33.61 %
III Quarter October - 84.78 % -69.9 % 193.44 %
II Quarter July - 81.53 % -27.54 % 7.29 %
I Quarter April 100.92 % 13.98 % -7 % 11.78 %
FY   - 78.92 % -48.91 % 51.85 %

Financial Statements
Pfizer Inc's first quarter 2022 Operating Income $ 9,401.00 millions PFE's Income Statement
Pfizer Inc's first quarter 2021 Operating Income $ 4,679.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Operating Income Growth >>


PFE Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - -51.14 % -89.74 % -86.1 %
III Quarter October - 9.46 % 7.54 % 158.91 %
II Quarter July - 19.92 % -24.7 % -3.35 %
I Quarter April 213.26 % 1272.14 % 167.43 % 90.92 %
FY (Year on Year)   - 78.92 % -48.91 % 51.85 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #17
Overall #237

Operating Income Y/Y Growth Statistics
High Average Low
49.34 % 0.67 % -49.17 %
(Sep 29 2019)   (Sep. 30, 2015)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #17
Overall #237
Operating Income Y/Y Growth Statistics
High Average Low
49.34 % 0.67 % -49.17 %
(Sep 29 2019)   (Sep. 30, 2015)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Pfizer Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
79375 % 1193.22 % -99.9 %
(March 31, 2010)  


PFE's I. Quarter Q/Q Operating Income Comment
Pfizer Inc achieved in the I. Quarter 2022 below company average Operating Income doubling of 213.26% quarter on quarter, to $ 9,401.00 millions.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 87.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #8
Overall #87
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #8
Overall #87
Operating Income Q/Q Growth Statistics
High Average Low
79375 % 1193.22 % -99.9 %
(March 31, 2010)  


PFE's I. Quarter Q/Q Operating Income Comment
Pfizer Inc achieved in the I. Quarter 2022 below company average Operating Income doubling of 213.26% quarter on quarter, to $ 9,401.00 millions.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 87.


Pfizer Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative Operating Income 12 Months Ending $ 24,155.00 $ 19,433.00 $ 16,773.00 $ 13,955.00 $ 11,435.00
Y / Y Operating Income Growth (TTM) 111.24 % 78.92 % 39.14 % -29.43 % -45.42 %
Year on Year Operating Income Growth Overall Ranking # 318 # 631 # 799 # 1848 # 1809
Seqeuential Operating Income Change (TTM) 24.3 % 15.86 % 20.19 % 22.04 % 5.28 %
Seq. Operating Income Growth (TTM) Overall Ranking # 237 # 295 # 439 # 770 # 1381




Cumulative Operating Income growth Comment
With 111.24% annual Operating Income growth, Pfizer Inc would report a record annual Operating Income surge if the fiscal year would end on Apr 03 2022.

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 318, from total ranking in previous quarter at 631.

Operating Income TTM Q/Q Growth Statistics
High Average Low
49.34 %
0.67 %
-49.17 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 25
Overall # 318

Operating Income TTM Y/Y Growth Statistics
High Average Low
111.24 %
5.63 %
-61.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 17
S&P 500 # 237
Cumulative Operating Income growth Comment
With 111.24% annual Operating Income growth, Pfizer Inc would report a record annual Operating Income surge if the fiscal year would end on Apr 03 2022.

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 318, from total ranking in previous quarter at 631.

Operating Income TTM Q/Q Growth Statistics
High Average Low
49.34 %
0.67 %
-49.17 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 25
Overall # 318

Operating Income TTM Y/Y Growth Statistics
High Average Low
111.24 %
5.63 %
-61.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 17
S&P 500 # 237




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PFE's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PFE's Competitors
Operating Income Growth for Pfizer Inc's Suppliers
Operating Income Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Operating Income surge for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Apr 03 2022
Pfizer Inc100.92%$ 100.919 millions
Staar Surgical Co62.16%$ 62.155 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CANG's Profile

Stock Price

CANG's Financials

Business Description

Fundamentals

Charts & Quotes

CANG's News

Suppliers

CANG's Competitors

Customers & Markets

Economic Indicators

CANG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071